IGHE and asthma: For example, the anti-IgE antibody, omalizumab, has been used as a steroid sparing drug in patients with severe asthma, but unfortunately its use is limited (Plosker and Keam, 2008) due to a high frequency of anaphylactic reaction and serum sickness (Harrison et al., 2015) and lack of cost-effectiveness.